| Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure CJ Reynolds, C Pade, JM Gibbons, AD Otter, KM Lin, D Muñoz Sandoval, ... Science 377 (6603), eabq1841, 2022 | 284 | 2022 |
| Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a … R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, M Clout, ... The Lancet 398 (10318), 2277-2287, 2021 | 131 | 2021 |
| Screening of wild deer populations for exposure to SARS‐CoV‐2 in the United Kingdom, 2020–2021 M Holding, AD Otter, S Dowall, K Takumi, B Hicks, T Coleman, ... Transboundary and Emerging Diseases 69 (5), e3244-e3249, 2022 | 15 | 2022 |
| Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara–Bavaria Nordic vaccine against mpox in children: a national … SN Ladhani, AC Dowell, S Jones, B Hicks, C Rowe, J Begum, ... The Lancet Infectious Diseases 23 (9), 1042-1050, 2023 | 10 | 2023 |
| Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals AD Otter, S Jones, B Hicks, D Bailey, H Callaby, C Houlihan, T Rampling, ... Nature Communications 14 (1), 5948, 2023 | 6 | 2023 |
| Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response I Doykov, T Baldwin, J Spiewak, KC Gilmour, JM Gibbons, C Pade, ... Cell Reports Methods 2 (9), 2022 | 6 | 2022 |
| Analogous humoral antigen recognition between monkeypox-infected and smallpox-vaccinated individuals AD Otter, S Jones, B Hicks, D Bailey, H Callaby, C Houlihan, T Rampling, ... MedRxiv, 2022.12. 22.22283648, 2022 | 5 | 2022 |
| Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins S Findlay-Wilson, L Easterbrook, S Smith, N Pope, G Humphries, ... Antiviral Research 203, 105332, 2022 | 4 | 2022 |
| Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)2 fragments S Findlay-Wilson, L Easterbrook, S Smith, N Pope, M Aldridge, ... Scientific Reports 13 (1), 13912, 2023 | | 2023 |
| Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F (ab′) 2 fragments S Findlay‑Wilson, L Easterbrook, S Smith, N Pope, M Aldridge, ... Scientific Reports 13, 2023 | | 2023 |
| Analogous Humoral Antigen Recognition between Smallpox-Vaccinated and Mpox-Infected Individuals A Otter, S Jones, B Hicks, D Bailey, H Callaby, C Houlihan, C Rowe, ... 17TH VACCINE CONGRESS O 12, 0 | | |
| Understanding the Impact of Primary Sars-Cov-2 Infection Prior to Vaccination A Otter, T Brooks, H White, H Selman, S Foulkes, E Monk, B Hicks, ... 17TH VACCINE CONGRESS O 1, 0 | | |
| Differential Antibody Dynamics to Multiple Mpox Antigens Following Two Doses of Mva-Bn (Imvanex) in a Longitudinal Cohort B Hicks, S Jones, C Rowe, A Otter 17TH VACCINE CONGRESS P 2, 0 | | |
